Cross-regulation of JAK and Src kinases (Q36360695)

13 August 2017

1 reference

title

Cross-regulation of JAK and Src kinases (English)

1 reference

13 August 2017

Evan Ingley

1

0 references

author name string

S Peter Klinken

series ordinal

2

1 reference

13 August 2017

1 March 2006

1 reference

13 August 2017

Growth Factors Journal

1 reference

13 August 2017

24

1 reference

13 August 2017

89-95

1 reference

13 August 2017

1

1 reference

Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase

13 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase csk and is involved in regulation of T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Activation and association of Stat3 with Src in v-Src-transformed cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

STAT proteins as novel targets for cancer therapy. Signal transducer an activator of transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Src kinases and not JAKs activate STATs during IL-3 induced myeloid cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Abrogation of interleukin-3 dependence of myeloid cells by the v-src oncogene requires SH2 and SH3 domains which specify activation of STATs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Socs1 binds to multiple signalling proteins and suppresses steel factor-dependent proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

A new protein containing an SH2 domain that inhibits JAK kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

CD45 tyrosine phosphatase inhibits erythroid differentiation of umbilical cord blood CD34+ cells associated with selective inactivation of Lyn.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Perturbed myelo/erythropoiesis in Lyn-deficient mice is similar to that in mice lacking the inhibitory phosphatases SHP-1 and SHIP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Sustained receptor activation and hyperproliferation in response to granulocyte colony-stimulating factor (G-CSF) in mice with a severe congenital neutropenia/acute myeloid leukemia-derived mutation in the G-CSF receptor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Jak3-independent trafficking of the common gamma chain receptor subunit: chaperone function of Jaks revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Thyroid hormone receptor-interacting protein 1 modulates cytokine and nuclear hormone signaling in erythroid cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Lyn deficiency reduces GATA-1, EKLF and STAT5, and induces extramedullary stress erythropoiesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

HS1 interacts with Lyn and is critical for erythropoietin-induced differentiation of erythroid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Molecular cloning of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

A gain-of-function mutation of JAK2 in myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Jak2 is essential for signaling through a variety of cytokine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Alternative activation of STAT1 and STAT3 in response to interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

JAKs, STATs and Src kinases in hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Src protein-tyrosine kinase structure and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

The pseudokinase domain is required for suppression of basal activity of Jak2 and Jak3 tyrosine kinases and for cytokine-inducible activation of signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Regulation of the Jak2 tyrosine kinase by its pseudokinase domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Interferon-induced nuclear signalling by Jak protein tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Cytoplasmic domains of the common beta-chain of the GM-CSF/IL-3/IL-5 receptors that are required for inducing differentiation or clonal suppression in myeloid leukaemic cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

A family of cytokine-inducible inhibitors of signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Lyn tyrosine kinase is essential for erythropoietin-induced differentiation of J2E erythroid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Regulation of Jak2 through the ubiquitin-proteasome pathway involves phosphorylation of Jak2 on Y1007 and interaction with SOCS-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Jak family of kinases in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

The size and genetic composition of virus-specific RNAs in the cytoplasm of cells producing avian sarcoma-leukosis viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Two putative protein-tyrosine kinases identified by application of the polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Inhibitors of cytokine signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Src kinases mediate STAT growth pathways in squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

21 January 2018

The Janus kinases (Jaks)

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Association of the interferon-dependent tyrosine kinase Tyk-2 with the hematopoietic cell phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Identification of an acquired JAK2 mutation in polycythemia vera

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

Unexpected effects of FERM domain mutations on catalytic activity of Jak3: structural implication for Janus kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190500368031

10.1080/08977190500368031

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16393697